nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—ABCG2—Sorafenib—liver cancer	0.122	0.276	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—liver cancer	0.0737	0.168	CbGbCtD
Cabazitaxel—CYP3A5—Sorafenib—liver cancer	0.0673	0.153	CbGbCtD
Cabazitaxel—CYP2C8—Sorafenib—liver cancer	0.0647	0.147	CbGbCtD
Cabazitaxel—ABCB1—Sorafenib—liver cancer	0.0438	0.0996	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—liver cancer	0.0266	0.0604	CbGbCtD
Cabazitaxel—CYP3A4—Sorafenib—liver cancer	0.0263	0.0597	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—liver cancer	0.0159	0.0362	CbGbCtD
Cabazitaxel—Mental disorder—Sorafenib—liver cancer	0.00121	0.00411	CcSEcCtD
Cabazitaxel—Malnutrition—Sorafenib—liver cancer	0.00121	0.00409	CcSEcCtD
Cabazitaxel—Erythema—Sorafenib—liver cancer	0.00121	0.00409	CcSEcCtD
Cabazitaxel—Dysgeusia—Sorafenib—liver cancer	0.00118	0.004	CcSEcCtD
Cabazitaxel—Muscle spasms—Sorafenib—liver cancer	0.00116	0.00393	CcSEcCtD
Cabazitaxel—Rectal haemorrhage—Epirubicin—liver cancer	0.00113	0.00383	CcSEcCtD
Cabazitaxel—Cellulitis—Epirubicin—liver cancer	0.00112	0.0038	CcSEcCtD
Cabazitaxel—Anaemia—Sorafenib—liver cancer	0.00111	0.00378	CcSEcCtD
Cabazitaxel—Lacrimation increased—Epirubicin—liver cancer	0.00111	0.00375	CcSEcCtD
Cabazitaxel—Leukopenia—Sorafenib—liver cancer	0.00108	0.00366	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Epirubicin—liver cancer	0.00108	0.00365	CcSEcCtD
Cabazitaxel—Cough—Sorafenib—liver cancer	0.00105	0.00357	CcSEcCtD
Cabazitaxel—Rectal haemorrhage—Doxorubicin—liver cancer	0.00104	0.00354	CcSEcCtD
Cabazitaxel—Hypertension—Sorafenib—liver cancer	0.00104	0.00353	CcSEcCtD
Cabazitaxel—Cellulitis—Doxorubicin—liver cancer	0.00104	0.00352	CcSEcCtD
Cabazitaxel—Arthralgia—Sorafenib—liver cancer	0.00103	0.00348	CcSEcCtD
Cabazitaxel—Myalgia—Sorafenib—liver cancer	0.00103	0.00348	CcSEcCtD
Cabazitaxel—Lacrimation increased—Doxorubicin—liver cancer	0.00102	0.00347	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00102	0.00346	CcSEcCtD
Cabazitaxel—Dry mouth—Sorafenib—liver cancer	0.001	0.0034	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Doxorubicin—liver cancer	0.000997	0.00338	CcSEcCtD
Cabazitaxel—Cystitis noninfective—Epirubicin—liver cancer	0.000996	0.00338	CcSEcCtD
Cabazitaxel—Cystitis—Epirubicin—liver cancer	0.000984	0.00334	CcSEcCtD
Cabazitaxel—Colitis—Epirubicin—liver cancer	0.000979	0.00332	CcSEcCtD
Cabazitaxel—Infection—Sorafenib—liver cancer	0.000978	0.00331	CcSEcCtD
Cabazitaxel—Candida infection—Epirubicin—liver cancer	0.000973	0.0033	CcSEcCtD
Cabazitaxel—Nervous system disorder—Sorafenib—liver cancer	0.000965	0.00327	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Sorafenib—liver cancer	0.000964	0.00327	CcSEcCtD
Cabazitaxel—Skin disorder—Sorafenib—liver cancer	0.000956	0.00324	CcSEcCtD
Cabazitaxel—Anorexia—Sorafenib—liver cancer	0.000938	0.00318	CcSEcCtD
Cabazitaxel—Bladder pain—Epirubicin—liver cancer	0.000922	0.00313	CcSEcCtD
Cabazitaxel—Cystitis noninfective—Doxorubicin—liver cancer	0.000921	0.00312	CcSEcCtD
Cabazitaxel—Cystitis—Doxorubicin—liver cancer	0.000911	0.00309	CcSEcCtD
Cabazitaxel—Colitis—Doxorubicin—liver cancer	0.000906	0.00307	CcSEcCtD
Cabazitaxel—Candida infection—Doxorubicin—liver cancer	0.000901	0.00305	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000897	0.00304	CcSEcCtD
Cabazitaxel—Sepsis—Epirubicin—liver cancer	0.000885	0.003	CcSEcCtD
Cabazitaxel—Dyspnoea—Sorafenib—liver cancer	0.000877	0.00297	CcSEcCtD
Cabazitaxel—Dyspepsia—Sorafenib—liver cancer	0.000866	0.00294	CcSEcCtD
Cabazitaxel—Decreased appetite—Sorafenib—liver cancer	0.000856	0.0029	CcSEcCtD
Cabazitaxel—Bladder pain—Doxorubicin—liver cancer	0.000853	0.00289	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Sorafenib—liver cancer	0.00085	0.00288	CcSEcCtD
Cabazitaxel—Fatigue—Sorafenib—liver cancer	0.000849	0.00288	CcSEcCtD
Cabazitaxel—Pain—Sorafenib—liver cancer	0.000842	0.00285	CcSEcCtD
Cabazitaxel—Constipation—Sorafenib—liver cancer	0.000842	0.00285	CcSEcCtD
Cabazitaxel—Sepsis—Doxorubicin—liver cancer	0.000819	0.00278	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Sorafenib—liver cancer	0.000805	0.00273	CcSEcCtD
Cabazitaxel—Renal failure acute—Epirubicin—liver cancer	0.000802	0.00272	CcSEcCtD
Cabazitaxel—Hot flush—Epirubicin—liver cancer	0.000791	0.00268	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Epirubicin—liver cancer	0.000784	0.00266	CcSEcCtD
Cabazitaxel—Abdominal pain—Sorafenib—liver cancer	0.000778	0.00264	CcSEcCtD
Cabazitaxel—Body temperature increased—Sorafenib—liver cancer	0.000778	0.00264	CcSEcCtD
Cabazitaxel—Cardiac failure—Epirubicin—liver cancer	0.000758	0.00257	CcSEcCtD
Cabazitaxel—Lethargy—Epirubicin—liver cancer	0.000755	0.00256	CcSEcCtD
Cabazitaxel—Renal failure acute—Doxorubicin—liver cancer	0.000742	0.00251	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00074	0.00251	CcSEcCtD
Cabazitaxel—Pain in extremity—Epirubicin—liver cancer	0.00074	0.00251	CcSEcCtD
Cabazitaxel—Hot flush—Doxorubicin—liver cancer	0.000732	0.00248	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Doxorubicin—liver cancer	0.000726	0.00246	CcSEcCtD
Cabazitaxel—Hypersensitivity—Sorafenib—liver cancer	0.000725	0.00246	CcSEcCtD
Cabazitaxel—Asthenia—Sorafenib—liver cancer	0.000706	0.00239	CcSEcCtD
Cabazitaxel—Cardiac arrest—Epirubicin—liver cancer	0.000704	0.00239	CcSEcCtD
Cabazitaxel—Cardiac failure—Doxorubicin—liver cancer	0.000702	0.00238	CcSEcCtD
Cabazitaxel—Lethargy—Doxorubicin—liver cancer	0.000699	0.00237	CcSEcCtD
Cabazitaxel—Dehydration—Epirubicin—liver cancer	0.000688	0.00233	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000685	0.00232	CcSEcCtD
Cabazitaxel—Pain in extremity—Doxorubicin—liver cancer	0.000685	0.00232	CcSEcCtD
Cabazitaxel—Dry skin—Epirubicin—liver cancer	0.000678	0.0023	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Epirubicin—liver cancer	0.000676	0.00229	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Epirubicin—liver cancer	0.000676	0.00229	CcSEcCtD
Cabazitaxel—Hypokalaemia—Epirubicin—liver cancer	0.000674	0.00228	CcSEcCtD
Cabazitaxel—Diarrhoea—Sorafenib—liver cancer	0.000673	0.00228	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—liver cancer	0.000669	0.00227	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000666	0.00226	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—liver cancer	0.000655	0.00222	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000653	0.00221	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—liver cancer	0.000651	0.00221	CcSEcCtD
Cabazitaxel—Dizziness—Sorafenib—liver cancer	0.000651	0.00221	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—liver cancer	0.000644	0.00218	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—liver cancer	0.00064	0.00217	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—liver cancer	0.000637	0.00216	CcSEcCtD
Cabazitaxel—Dry skin—Doxorubicin—liver cancer	0.000628	0.00213	CcSEcCtD
Cabazitaxel—Vomiting—Sorafenib—liver cancer	0.000626	0.00212	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—liver cancer	0.000625	0.00212	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—liver cancer	0.000625	0.00212	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—liver cancer	0.000623	0.00211	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—liver cancer	0.000619	0.0021	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000617	0.00209	CcSEcCtD
Cabazitaxel—Headache—Sorafenib—liver cancer	0.000617	0.00209	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—liver cancer	0.000606	0.00205	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000604	0.00205	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—liver cancer	0.000598	0.00203	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—liver cancer	0.000598	0.00203	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—liver cancer	0.000596	0.00202	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—liver cancer	0.000594	0.00202	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—liver cancer	0.000592	0.00201	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—liver cancer	0.000591	0.002	CcSEcCtD
Cabazitaxel—Nausea—Sorafenib—liver cancer	0.000585	0.00198	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—liver cancer	0.000579	0.00196	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—liver cancer	0.000577	0.00196	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—liver cancer	0.000574	0.00194	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—liver cancer	0.00057	0.00193	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—liver cancer	0.00057	0.00193	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—liver cancer	0.000561	0.0019	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—liver cancer	0.000559	0.0019	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—liver cancer	0.000554	0.00188	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—liver cancer	0.000554	0.00188	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—liver cancer	0.000553	0.00188	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—liver cancer	0.000553	0.00188	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00055	0.00186	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—liver cancer	0.000547	0.00185	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—liver cancer	0.000544	0.00184	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—liver cancer	0.000535	0.00182	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—liver cancer	0.000534	0.00181	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—liver cancer	0.000531	0.0018	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—liver cancer	0.000528	0.00179	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—liver cancer	0.000528	0.00179	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—liver cancer	0.000519	0.00176	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—liver cancer	0.000517	0.00175	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—liver cancer	0.000513	0.00174	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—liver cancer	0.000513	0.00174	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—liver cancer	0.000509	0.00173	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—liver cancer	0.000506	0.00171	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—liver cancer	0.000504	0.00171	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—liver cancer	0.000503	0.00171	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—liver cancer	0.000503	0.00171	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—liver cancer	0.000502	0.0017	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—liver cancer	0.000478	0.00162	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—liver cancer	0.000477	0.00162	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—liver cancer	0.000475	0.00161	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—liver cancer	0.000475	0.00161	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—liver cancer	0.000471	0.0016	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—liver cancer	0.000468	0.00159	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—liver cancer	0.000467	0.00158	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—liver cancer	0.000466	0.00158	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—liver cancer	0.000465	0.00157	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—liver cancer	0.000464	0.00157	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—liver cancer	0.000462	0.00157	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—liver cancer	0.000461	0.00156	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—liver cancer	0.000459	0.00156	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—liver cancer	0.000457	0.00155	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—liver cancer	0.000452	0.00153	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—liver cancer	0.000449	0.00152	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—liver cancer	0.000446	0.00151	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—liver cancer	0.000446	0.00151	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—liver cancer	0.000443	0.0015	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—liver cancer	0.000442	0.0015	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—liver cancer	0.00044	0.00149	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—liver cancer	0.00044	0.00149	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—liver cancer	0.000436	0.00148	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—liver cancer	0.000431	0.00146	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—liver cancer	0.00043	0.00146	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—liver cancer	0.000429	0.00145	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—liver cancer	0.000428	0.00145	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—liver cancer	0.000427	0.00145	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—liver cancer	0.000425	0.00144	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—liver cancer	0.000423	0.00143	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—liver cancer	0.000419	0.00142	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—liver cancer	0.000415	0.00141	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—liver cancer	0.000414	0.0014	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—liver cancer	0.000412	0.0014	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—liver cancer	0.000412	0.0014	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—liver cancer	0.000412	0.0014	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—liver cancer	0.000404	0.00137	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—liver cancer	0.000402	0.00136	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—liver cancer	0.0004	0.00136	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—liver cancer	0.000399	0.00135	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—liver cancer	0.000399	0.00135	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—liver cancer	0.000396	0.00134	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—liver cancer	0.000389	0.00132	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—liver cancer	0.000385	0.0013	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—liver cancer	0.000383	0.0013	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—liver cancer	0.000381	0.00129	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—liver cancer	0.000379	0.00129	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—liver cancer	0.000379	0.00129	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—liver cancer	0.000379	0.00129	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—liver cancer	0.000378	0.00128	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000377	0.00128	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—liver cancer	0.000375	0.00127	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—liver cancer	0.000372	0.00126	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—liver cancer	0.000371	0.00126	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—liver cancer	0.000371	0.00126	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—liver cancer	0.000369	0.00125	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—liver cancer	0.000367	0.00124	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—liver cancer	0.000364	0.00123	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—liver cancer	0.000361	0.00123	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—liver cancer	0.00036	0.00122	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—liver cancer	0.000357	0.00121	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—liver cancer	0.000356	0.00121	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—liver cancer	0.000356	0.00121	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—liver cancer	0.000355	0.0012	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—liver cancer	0.000353	0.0012	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—liver cancer	0.000351	0.00119	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—liver cancer	0.000351	0.00119	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—liver cancer	0.000351	0.00119	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—liver cancer	0.00035	0.00119	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000349	0.00118	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—liver cancer	0.000347	0.00118	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—liver cancer	0.000347	0.00118	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—liver cancer	0.000343	0.00116	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—liver cancer	0.00034	0.00115	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—liver cancer	0.000339	0.00115	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—liver cancer	0.000337	0.00114	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—liver cancer	0.000334	0.00113	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000331	0.00112	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—liver cancer	0.00033	0.00112	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—liver cancer	0.00033	0.00112	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—liver cancer	0.000328	0.00111	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—liver cancer	0.000327	0.00111	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—liver cancer	0.000327	0.00111	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—liver cancer	0.000324	0.0011	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—liver cancer	0.000321	0.00109	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—liver cancer	0.00032	0.00109	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—liver cancer	0.000316	0.00107	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—liver cancer	0.000314	0.00107	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—liver cancer	0.000314	0.00106	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—liver cancer	0.000314	0.00106	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—liver cancer	0.000311	0.00105	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—liver cancer	0.000311	0.00105	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000307	0.00104	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—liver cancer	0.000302	0.00102	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—liver cancer	0.0003	0.00102	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—liver cancer	0.0003	0.00102	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—liver cancer	0.000297	0.00101	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—liver cancer	0.000296	0.001	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—liver cancer	0.000293	0.000992	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000291	0.000985	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—liver cancer	0.00029	0.000984	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—liver cancer	0.000288	0.000976	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—liver cancer	0.000288	0.000976	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—liver cancer	0.000288	0.000975	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—liver cancer	0.000288	0.000975	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—liver cancer	0.000277	0.00094	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—liver cancer	0.000275	0.000933	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—liver cancer	0.000268	0.000909	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—liver cancer	0.000266	0.000902	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—liver cancer	0.000266	0.000902	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—liver cancer	0.000261	0.000885	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—liver cancer	0.000249	0.000844	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—liver cancer	0.000248	0.000841	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—liver cancer	0.000241	0.000819	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—liver cancer	0.000241	0.000815	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—liver cancer	0.000231	0.000784	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—liver cancer	0.00023	0.000781	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—liver cancer	0.000228	0.000773	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—liver cancer	0.000223	0.000755	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—liver cancer	0.000216	0.000732	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—liver cancer	0.000214	0.000725	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—liver cancer	0.000211	0.000715	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—liver cancer	0.0002	0.000678	CcSEcCtD
Cabazitaxel—ABCG2—Metabolism—GSTA1—liver cancer	4.59e-05	0.000173	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1A—liver cancer	4.58e-05	0.000173	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NAT2—liver cancer	4.54e-05	0.000171	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—RAF1—liver cancer	4.49e-05	0.000169	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CRABP1—liver cancer	4.49e-05	0.000169	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	4.49e-05	0.000169	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TAT—liver cancer	4.48e-05	0.000169	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYCS—liver cancer	4.45e-05	0.000168	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.37e-05	0.000165	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GGT1—liver cancer	4.37e-05	0.000165	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GOT1—liver cancer	4.37e-05	0.000165	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALDOB—liver cancer	4.35e-05	0.000164	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—liver cancer	4.33e-05	0.000163	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	4.32e-05	0.000163	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.31e-05	0.000163	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CTNNB1—liver cancer	4.27e-05	0.000161	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—liver cancer	4.25e-05	0.00016	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CRABP1—liver cancer	4.15e-05	0.000157	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	4.15e-05	0.000157	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—liver cancer	4.15e-05	0.000157	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.14e-05	0.000156	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—liver cancer	4.11e-05	0.000155	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.09e-05	0.000154	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.04e-05	0.000152	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GLUL—liver cancer	4.04e-05	0.000152	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CPT1B—liver cancer	4.04e-05	0.000152	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—liver cancer	3.92e-05	0.000148	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HPGDS—liver cancer	3.92e-05	0.000148	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CTNNB1—liver cancer	3.91e-05	0.000147	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.9e-05	0.000147	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NR1H4—liver cancer	3.89e-05	0.000147	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HMOX1—liver cancer	3.87e-05	0.000146	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTA3—liver cancer	3.83e-05	0.000144	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	3.8e-05	0.000143	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—liver cancer	3.8e-05	0.000143	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.79e-05	0.000143	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HPGDS—liver cancer	3.63e-05	0.000137	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTM1—liver cancer	3.61e-05	0.000136	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.55e-05	0.000134	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.51e-05	0.000132	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTA4—liver cancer	3.5e-05	0.000132	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CPT1B—liver cancer	3.5e-05	0.000132	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GLUL—liver cancer	3.5e-05	0.000132	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PSMA4—liver cancer	3.5e-05	0.000132	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PSMD10—liver cancer	3.5e-05	0.000132	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	3.48e-05	0.000131	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1A1—liver cancer	3.42e-05	0.000129	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	3.41e-05	0.000129	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTA2—liver cancer	3.41e-05	0.000129	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—liver cancer	3.41e-05	0.000129	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GOT2—liver cancer	3.4e-05	0.000128	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NR1H4—liver cancer	3.37e-05	0.000127	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	3.33e-05	0.000126	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.32e-05	0.000125	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.32e-05	0.000125	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTA3—liver cancer	3.32e-05	0.000125	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTA1—liver cancer	3.29e-05	0.000124	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.29e-05	0.000124	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NAT2—liver cancer	3.25e-05	0.000123	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PSMA4—liver cancer	3.24e-05	0.000122	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PSMD10—liver cancer	3.24e-05	0.000122	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.21e-05	0.000121	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.2e-05	0.000121	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP2E1—liver cancer	3.2e-05	0.000121	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—MTHFR—liver cancer	3.19e-05	0.00012	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GOT2—liver cancer	3.15e-05	0.000119	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.14e-05	0.000118	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARA—liver cancer	3.13e-05	0.000118	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALDOB—liver cancer	3.12e-05	0.000118	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—liver cancer	3.12e-05	0.000118	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UGDH—liver cancer	3.1e-05	0.000117	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.1e-05	0.000117	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	3.09e-05	0.000116	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CPT1B—liver cancer	3.05e-05	0.000115	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GLUL—liver cancer	3.05e-05	0.000115	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTA4—liver cancer	3.03e-05	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	3.01e-05	0.000114	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYCS—liver cancer	2.99e-05	0.000113	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CRABP1—liver cancer	2.98e-05	0.000112	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.96e-05	0.000112	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP2E1—liver cancer	2.96e-05	0.000112	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTA2—liver cancer	2.95e-05	0.000111	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NR1H4—liver cancer	2.94e-05	0.000111	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GGT1—liver cancer	2.94e-05	0.000111	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GOT1—liver cancer	2.94e-05	0.000111	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EPT1—liver cancer	2.91e-05	0.00011	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.9e-05	0.000109	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTA3—liver cancer	2.89e-05	0.000109	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTA1—liver cancer	2.85e-05	0.000108	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NAT2—liver cancer	2.82e-05	0.000106	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.81e-05	0.000106	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	2.79e-05	0.000105	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.78e-05	0.000105	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYCS—liver cancer	2.77e-05	0.000104	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TAT—liver cancer	2.76e-05	0.000104	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GGT1—liver cancer	2.72e-05	0.000103	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GOT1—liver cancer	2.72e-05	0.000103	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.71e-05	0.000102	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALDOB—liver cancer	2.7e-05	0.000102	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CG—liver cancer	2.68e-05	0.000101	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.66e-05	0.000101	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.66e-05	0.0001	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTA4—liver cancer	2.64e-05	9.96e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—liver cancer	2.64e-05	9.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HPGDS—liver cancer	2.6e-05	9.81e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HMOX1—liver cancer	2.6e-05	9.81e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—liver cancer	2.58e-05	9.75e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CRABP1—liver cancer	2.58e-05	9.73e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTA2—liver cancer	2.57e-05	9.71e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTA1—liver cancer	2.48e-05	9.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.48e-05	9.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.46e-05	9.29e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NAT2—liver cancer	2.46e-05	9.26e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—liver cancer	2.44e-05	9.21e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTM1—liver cancer	2.42e-05	9.14e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HMOX1—liver cancer	2.41e-05	9.08e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALDOB—liver cancer	2.35e-05	8.88e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CD—liver cancer	2.35e-05	8.88e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ALB—liver cancer	2.32e-05	8.77e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.32e-05	8.76e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PSMD10—liver cancer	2.32e-05	8.75e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PSMA4—liver cancer	2.32e-05	8.75e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1A1—liver cancer	2.3e-05	8.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.26e-05	8.53e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GOT2—liver cancer	2.26e-05	8.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HPGDS—liver cancer	2.25e-05	8.5e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CRABP1—liver cancer	2.25e-05	8.47e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.25e-05	8.47e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—liver cancer	2.24e-05	8.46e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.24e-05	8.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.19e-05	8.26e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—liver cancer	2.14e-05	8.08e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1A1—liver cancer	2.13e-05	8.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2E1—liver cancer	2.12e-05	8e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARA—liver cancer	2.1e-05	7.92e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—liver cancer	2.05e-05	7.74e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.04e-05	7.7e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.01e-05	7.6e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PSMA4—liver cancer	2.01e-05	7.58e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PSMD10—liver cancer	2.01e-05	7.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYCS—liver cancer	1.98e-05	7.49e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—liver cancer	1.98e-05	7.48e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HPGDS—liver cancer	1.96e-05	7.41e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GOT2—liver cancer	1.95e-05	7.37e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GGT1—liver cancer	1.95e-05	7.35e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GOT1—liver cancer	1.95e-05	7.35e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARA—liver cancer	1.95e-05	7.34e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.89e-05	7.12e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GLUL—liver cancer	1.88e-05	7.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CPT1B—liver cancer	1.88e-05	7.08e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.85e-05	6.97e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2E1—liver cancer	1.84e-05	6.93e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NR1H4—liver cancer	1.81e-05	6.83e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.8e-05	6.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA3—liver cancer	1.78e-05	6.71e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.78e-05	6.71e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PSMA4—liver cancer	1.75e-05	6.6e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PSMD10—liver cancer	1.75e-05	6.6e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—liver cancer	1.75e-05	6.6e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—liver cancer	1.74e-05	6.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HMOX1—liver cancer	1.73e-05	6.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYCS—liver cancer	1.72e-05	6.48e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GOT2—liver cancer	1.7e-05	6.42e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GGT1—liver cancer	1.69e-05	6.36e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GOT1—liver cancer	1.69e-05	6.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.67e-05	6.29e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—liver cancer	1.67e-05	6.28e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA4—liver cancer	1.63e-05	6.14e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—liver cancer	1.61e-05	6.06e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—liver cancer	1.61e-05	6.06e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2E1—liver cancer	1.6e-05	6.04e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA2—liver cancer	1.59e-05	5.98e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.58e-05	5.97e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALB—liver cancer	1.56e-05	5.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTA1—liver cancer	1.53e-05	5.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1A1—liver cancer	1.52e-05	5.75e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—liver cancer	1.52e-05	5.71e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NAT2—liver cancer	1.51e-05	5.71e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.51e-05	5.69e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYCS—liver cancer	1.5e-05	5.65e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HMOX1—liver cancer	1.49e-05	5.64e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GGT1—liver cancer	1.47e-05	5.54e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GOT1—liver cancer	1.47e-05	5.54e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—liver cancer	1.46e-05	5.52e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDOB—liver cancer	1.45e-05	5.47e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALB—liver cancer	1.45e-05	5.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—liver cancer	1.42e-05	5.36e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARA—liver cancer	1.39e-05	5.26e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—liver cancer	1.39e-05	5.25e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CRABP1—liver cancer	1.38e-05	5.22e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—liver cancer	1.38e-05	5.2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—liver cancer	1.32e-05	4.98e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1A1—liver cancer	1.32e-05	4.98e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HMOX1—liver cancer	1.3e-05	4.91e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—liver cancer	1.28e-05	4.81e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—liver cancer	1.25e-05	4.72e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—liver cancer	1.23e-05	4.64e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—liver cancer	1.21e-05	4.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPGDS—liver cancer	1.21e-05	4.56e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARA—liver cancer	1.21e-05	4.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—liver cancer	1.19e-05	4.5e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—liver cancer	1.15e-05	4.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1A1—liver cancer	1.15e-05	4.34e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.08e-05	4.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PSMA4—liver cancer	1.08e-05	4.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PSMD10—liver cancer	1.08e-05	4.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—liver cancer	1.07e-05	4.04e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARA—liver cancer	1.05e-05	3.97e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—liver cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GOT2—liver cancer	1.05e-05	3.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALB—liver cancer	1.04e-05	3.91e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—liver cancer	1.03e-05	3.9e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—liver cancer	1.02e-05	3.85e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—liver cancer	9.98e-06	3.76e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2E1—liver cancer	9.86e-06	3.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYCS—liver cancer	9.23e-06	3.48e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—liver cancer	9.15e-06	3.45e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—liver cancer	9.09e-06	3.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GGT1—liver cancer	9.05e-06	3.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GOT1—liver cancer	9.05e-06	3.41e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—liver cancer	9.01e-06	3.4e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALB—liver cancer	8.97e-06	3.38e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—liver cancer	8.69e-06	3.28e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—liver cancer	8.4e-06	3.17e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—liver cancer	8.13e-06	3.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMOX1—liver cancer	8.02e-06	3.03e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—liver cancer	7.92e-06	2.99e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—liver cancer	7.92e-06	2.99e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALB—liver cancer	7.82e-06	2.95e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—liver cancer	7.78e-06	2.94e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—liver cancer	7.47e-06	2.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1A1—liver cancer	7.08e-06	2.67e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—liver cancer	6.9e-06	2.6e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—liver cancer	6.86e-06	2.59e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—liver cancer	6.6e-06	2.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARA—liver cancer	6.48e-06	2.44e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—liver cancer	6.36e-06	2.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—liver cancer	5.58e-06	2.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—liver cancer	5.55e-06	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—liver cancer	5.36e-06	2.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—liver cancer	4.88e-06	1.84e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—liver cancer	4.83e-06	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALB—liver cancer	4.82e-06	1.82e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—liver cancer	4.55e-06	1.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—liver cancer	4.25e-06	1.6e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—liver cancer	4.21e-06	1.59e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—liver cancer	3.94e-06	1.49e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—liver cancer	3.44e-06	1.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—liver cancer	2.59e-06	9.78e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—liver cancer	2.12e-06	7.99e-06	CbGpPWpGaD
